Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$2.6B |
| 2 |
Abbott
ABT
|
+$1.29B |
| 3 |
Home Depot
HD
|
+$1.03B |
| 4 |
Devon Energy
DVN
|
+$888M |
| 5 |
PepsiCo
PEP
|
+$880M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$1.6B |
| 2 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$1.5B |
| 3 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$1.34B |
| 4 |
Texas Instruments
TXN
|
+$1.32B |
| 5 |
Coterra Energy
CTRA
|
+$789M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.11% |
| 2 | Financials | 10.61% |
| 3 | Healthcare | 10.33% |
| 4 | Miscellaneous | 9.93% |
| 5 | Industrials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2926
Foster
FSTR
$368M
| $1.29M | ﹤0.01% |
28,490
+2,068
| +8% | +$77.1K |
2024 Q2
8 quarters
|
|
2927
Consolidated Water Co
CWCO
$492M
| $1.29M | ﹤0.01% |
43,567
+2,422
| +6% | +$75.9K |
2015 Q2
44 quarters
|
|
2928
Bridgewater Bancshares
BWB
$569M
| $1.28M | ﹤0.01% |
60,936
+5,976
| +11% | +$113K |
2018 Q2
32 quarters
|
|
2929
RBB Bancorp
RBB
$435M
| $1.28M | ﹤0.01% |
46,609
+3,856
| +9% | +$92.5K |
2017 Q4
34 quarters
|
|
2930
Merlin Inc
MRLN
$121M
| $1.28M | ﹤0.01% |
+224,414
| New | +$1.9M |
2026 Q2
0 quarters
|
|
2931
Aquestive Therapeutics
AQST
$604M
| $1.27M | ﹤0.01% |
306,394
+38,975
| +15% | +$164K |
2023 Q2
12 quarters
|
|
2932
Orion Office REIT
ONL
$123M
| $1.27M | ﹤0.01% |
440,642
+125,305
| +40% | +$343K |
2021 Q4
18 quarters
|
|
2933
SIGA Technologies
SIGA
$227M
| $1.27M | ﹤0.01% |
349,820
+9,499
| +3% | +$42.5K |
2018 Q2
32 quarters
|
|
2934
Contango Silver & Gold Inc
CTGO
$548M
| $1.27M | ﹤0.01% |
80,558
+18,274
| +29% | +$376K |
2023 Q2
12 quarters
|
|
2935
Avidia Bancorp
AVBC
$408M
| $1.27M | ﹤0.01% |
60,567
+50,567
| +506% | +$1.01M |
2025 Q3
3 quarters
|
|
2936
M-tron Industries
MPTI
$304M
| $1.27M | ﹤0.01% |
12,807
+4,149
| +48% | +$330K |
2025 Q2
4 quarters
|
|
2937
Citizens & Northern Corp
CZNC
$453M
| $1.27M | ﹤0.01% |
54,317
+4,870
| +10% | +$108K |
2013 Q2
52 quarters
|
|
2938
Bright Minds Biosciences
DRUG
$533M
| $1.27M | ﹤0.01% |
18,032
+2,714
| +18% | +$213K |
2025 Q2
4 quarters
|
|
2939
Colony Bankcorp
CBAN
$424M
| $1.26M | ﹤0.01% |
62,828
+4,784
| +8% | +$96.7K |
2022 Q2
16 quarters
|
|
2940
Enhanced Group Inc
ENHA
$205M
| $1.26M | ﹤0.01% |
+439,116
| New | +$2.93M |
2026 Q2
0 quarters
|
|
2941
American Integrity Insurance
AII
$531M
| $1.26M | ﹤0.01% |
66,877
+1,707
| +3% | +$30.9K |
2025 Q2
4 quarters
|
|
2942
Neuropace
NPCE
$446M
| $1.24M | ﹤0.01% |
77,831
+8,020
| +11% | +$129K |
2024 Q2
8 quarters
|
|
2943
X4 Pharmaceuticals
XFOR
$280M
| $1.23M | ﹤0.01% |
263,264
+196,515
| +294% | +$806K |
2025 Q4
2 quarters
|
|
2944
Starling Oncology
STLN
$705M
| $1.23M | ﹤0.01% |
226,007
+11,092
| +5% | +$46.6K |
2025 Q2
4 quarters
|
|
2945
Health Catalyst
HCAT
$132M
| $1.22M | ﹤0.01% |
615,504
+8,646
| +1% | +$12.5K |
2019 Q3
27 quarters
|
|
2946
iShares Russell 2000 Value ETF
IWN
$13.8B
| $1.22M | ﹤0.01% |
5,508
-288
| -5% | -$60.3K |
2023 Q3
11 quarters
|
|
2947
Gyre Therapeutics
GYRE
$728M
| $1.21M | ﹤0.01% |
184,286
+19,048
| +12% | +$130K |
2024 Q2
8 quarters
|
|
2948
Ponce Financial Group
PDLB
$487M
| $1.21M | ﹤0.01% |
60,801
+6,229
| +11% | +$114K |
2022 Q1
17 quarters
|
|
2949
Farmers & Merchants Bancorp
FMAO
$484M
| $1.2M | ﹤0.01% |
39,291
+5,350
| +16% | +$148K |
2022 Q2
16 quarters
|
|
2950
Matrix Service
MTRX
$296M
| $1.2M | ﹤0.01% |
87,394
+16,606
| +23% | +$214K |
2013 Q2
52 quarters
|
|
Similar funds
Charles Schwab's Q2 2026 Portfolio in Review
As of Q2 2026, Charles Schwab held 3,591 positions worth $751B, up 15% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab's Q2 2026 filing shows 136 new, 2,145 increased, 1,132 reduced and 153 closed positions. Its largest new stake was Honeywell Aerospace: 2,031,187 shares worth $449M. The largest sale was Qualcomm, an estimated $1.6B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2026 buy was Honeywell Aerospace: 2,031,187 shares worth $449M.
- Charles Schwab added most to Schwab US Large-Cap Growth ETF in Q2 2026, an estimated $2.6B increase.
- Charles Schwab's biggest Q2 2026 reduction was Qualcomm, cutting an estimated $1.6B.
- Charles Schwab fully exited Coterra Energy in Q2 2026, selling an estimated $789M.
- Charles Schwab's ten largest holdings make up 22% of its $751B portfolio in Q2 2026.
- Charles Schwab opened 136 new positions and closed 153 in Q2 2026.
- Charles Schwab's portfolio value rose 15% quarter-over-quarter to $751B.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.